Dispatch Bio

Dispatch Bio is a biotechnology company developing a universal treatment across solid tumors, with the goal of helping cancer patients achieve cures. Its Flare platform combines immunotherapy with a tumor-specific viral vector, both engineered to clear tumor cells with precision and power. It aims to expand the curative potential of immunotherapies and help patients continue their lives cancer-free through this novel approach.